Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 ...

Eli Lilly and Novo Nordisk May Soon Sell Weight Loss Drugs on the Planned TrumpRx. Could This Further Boost the Healthcare ...

Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

Eli Lilly's weight-loss therapy Mounjaro became India's top-selling drug by value in October, data showed on Friday, ...

The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...

The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...

(Reuters) -U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo ...

Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...